Skip to main content
SpringerLink
Log in

Reduced Levels of DEAD-Box Proteins DBP-RB and p72 in Fetal Down Syndrome Brains

  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Down syndrome (DS) is characterized by abnormal brain morphology and neurological and behavioral functions. The pivotal role of helicases in brain development, growth, and differentiation made us evaluate three DEAD BOX proteins, DEAD-box protein 1 (DBP-RB), DEAD-box protein 3 (HLP2), DEAD-box protein 72 (P72), and the RuvB-like DNA helicase (TIP49b), in fetal brain of controls and DS subjects, using two-dimensional electrophoresis with subsequent mass spectroscopic (MALDI-MS) identification. HLP2 and TIP49b brain levels were comparable between DS and controls, and protein levels of p72 and DBP-RB were significantly reduced in DS fetal cortex (p72: 2.04 ± 1.90 vs. 5.57 ± 2.56 in controls, p < 0.01; DBP-RB: 0.58 ± 0.94 vs. 1.90 ± 0.97 in controls, p < 0.01). Impairment of the helicases p72 and DBP-RB may reflect or lead to deficient growth and differentiation of brain development early in life and can be considered pathogenetic factors along with the reported deficits of transcription, splicing, and elongation factors already described in fetal DS brains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. De la Monte, S. M. 1999. Molecular abnormalities of the brain in Down syndrome: relevance to Alzheimer's neurodegeneration. Pages 161-177, in Lubec, G. (ed.), The Molecular Biology of Down Syndrome, Springer, Wien-New York.

    Google Scholar 

  2. Epstein, C. J. 1995. Down syndrome (Trisomy 21). Pages 749-794, in Scriver, C. R., Beaudet, A. L., Sly, W. S., and Valle, D. (eds.), The Metabolic and Molecular Basis of Inherited Disease, McGraw-Hill, New York.

    Google Scholar 

  3. Wisniewki, K. E. 1990. Down syndrome children often have brain with maturation delay, retardation of growth, and cortical dysgenesis. Am. J. Med. Genet. Suppl. 7:274-281.

    Google Scholar 

  4. Schmidt-Sidor, B., Wisniewski, K. E., Shepard, T. H., and Sersen, A. 1990. Brain growth in Down syndrome subjects 15 to 22 weeks of gestational age and birth to 60 months. Clin. Neuropathol. 9:181-190.

    Google Scholar 

  5. Freidl, M., Gulesserian, T., Lubec, G., Fountoulakis, M., and Lubec, B. 2001. Deterioration of the transcriptional, splicing and elongation machinery in brain of fetal Down Syndrome J. Neural. Transm. Suppl. 61:47-58.

    Google Scholar 

  6. Labudova, O., Krapfenbauer, K., Moenkemann, H., Rink, H., Kitzmüller, E., and Cairns, N. 1998. Decreased transcription factor junD in brains of patients with Down Syndrome. Neurosci. Lett. 252:159-162.

    Google Scholar 

  7. Lubec, G., Nonaka, M., Krapfenbauer, K., Gratzer, M., Cairns, N., and Fountoulakis, M. 1999. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. Pages 161-177, in Lubec, G. (ed.), The Molecular Biology of Down Syndrome, Springer, Wien-New York.

    Google Scholar 

  8. Greber-Platzer, S., Schatzmann-Turhani, D., Cairns, N., Balcz, B., and Lubec, G. 1999. Expression of the transcription factor ETS2 in brain of patients with Down syndrome·evidence against the overexpression-gene dosage hypothesis. J. Neural. Transm. Suppl. 57:269-282.

    Google Scholar 

  9. Greber-Platzer, S., Schatzmann-Turhani, D., Wollenek, G., and Lubec, G. 1999. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21 is not overexpressed in hearts of patients with Down syndrome. Biochem. Biophys. Res. Comm. 254:395-399.

    Google Scholar 

  10. Linder, P., Lasko, P. F., Ashburner, M., Leroy, P., Nielsen, P. J., and Nishi, K. 1989. Birth of the D-E-A-D box. Nature 337:121-122.

    Google Scholar 

  11. Heinlein, U. A. O. 1998. DEAD box for the living. J. Pathol. 184:345-347.

    Google Scholar 

  12. De la Cruz, J., Kressler, D., and Linder, P. 1999. Unwinding RNA in Saccharomyces cerevisiae: DEAD-box proteins and related families. TIBS 24:192-198.

    Google Scholar 

  13. Sowden, J., Putt, W., Morrison, K., Beddington, R., and Edwards, Y. 1995. The embryonic RNA helicase gene (ERH): a new member of the DEAD box family of RNA helicases. Biochem. J. 308:839-846.

    Google Scholar 

  14. Lamm, G. M., Nicol, S. M., Fuller-Pace, F. V., and Lamond, A. I. 1996. P72: a human nuclear DEAD box protein highly related to p68. Nucleic Acids Res. 24:3739-3747.

    Google Scholar 

  15. Stevenson, R. J., Hamilton, S. J., MacCallum, D. E., Hall, P. A., and Fuller-Pace, F. V. 1998. Expression of the 'DEAD box' RNA helicase p68 is developmentally and growth regulated and correlates with organ differentiation/maturation in the fetus. J. Pathol. 184:351-359.

    Google Scholar 

  16. Ip, F. C. F., Chung, S. S. K., Fu, W.-Y., and Ip, N. Y. 2000. Developmental and tissue-specific expression of DEAD box protein p72. Neuroreport 11:457-462.

    Google Scholar 

  17. George, R. E., Kenyon, R. M., McGuckin, A. G., Malcolm, A. J., Pearson, A. D. J., and Lunec, J. 1996. Investigation of coamplification of the candidate genes ornithine decarboxylase, ribonucleotide reductase, syndecan-1 and a DEAD box gene, DDX1, with N-myc in neuroblastoma. Oncogene 12:1583-1587.

    Google Scholar 

  18. Kuroda, H., White, P. S., Sulman, E. P., Manohar, C. F., Reiter, J. L., and Cohn, S. L. 1996. Physical mapping of the DDX1 gene to 340 kb 59 of MYCN. Oncogene 13:1561-1565.

    Google Scholar 

  19. Manohar, C. F., Salwen, H. R., Brodeur, G. M., and Cohn, S. L. 1995. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Genes Chromosom. Cancer 14:196-203.

    Google Scholar 

  20. Godbout, R., Packer, M., and Bie, W. 1998. Overexpression of a DEAD box protein DDX1 in neuroblastoma and retinoblastoma cell lines. J. Biol. Chem. 273:21161-21168.

    Google Scholar 

  21. Chuang, R.-Y., Weaver, P. L., Liu, Z., and Chang, T.-H. 1997. Requirement of the DEAD-box protein Ded1p for messenger RNA translation. Science 275:1468-1471.

    Google Scholar 

  22. Lahn, B. T. and Page, D. C. 1997. Functional coherence of the human Y chromosome. Science 278:675-680.

    Google Scholar 

  23. Qiu, X.-B., Lin, Y.-L., Thome, K. C., Pian, P., Schlegel, B. P., and Weremowicz, S. 1998. An eukaryotic RuvB-like protein (RUVBL1) essential for growth. J. Biol. Chem. 273:27786-27793.

    Google Scholar 

  24. Kanemaki, M., Kurokawa, Y., Matsu-ura, T., Makino, Y., Masani, A., and Okazaki, K.-I. 1999. TIP49b, a new RuvB-like DNA helicase, is included in a complex together with another RuvB-like DNA helicase, TIP49a. J. Biol. Chem. 274:22437-22444.

    Google Scholar 

  25. Bradford, M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248-254.

    Google Scholar 

  26. Langen, H., Roder, D., Juranville, J., and Fountoulakis, M. 1997. Effect of protein application mode and acrylamide concentration on the resolution of protein spots separated by two dimensional gel electrophoresis. Electrophoresis 18:2085-2090.

    Google Scholar 

  27. Fountoulakis, M. and Langen, H. 1997. Identification of proteins by matrix-assisted laser desorption ionisation-mass spectroscopy following in-gel digestion in low-salt nonvolatile buffer and simplified peptide recovery. Anal. Biochem. 250:153-156.

    Google Scholar 

  28. Berndt, P., Hobolm, U., and Langen, H. 1999. Reliable automatic protein identification from matrix-assisted laser desorption/ ionisation mass spectrometric peptide fingerprints. Electrophoresis 20:3521-3526.

    Google Scholar 

  29. Wassarman, D. A. and Steitz, J. A. 1991. Alive with DEAD proteins. Nature 349:463-464.

    Google Scholar 

  30. Schwer, B. and Guthrie, C. 1991. PRP16 is an RNA-dependent ATPase that interacts transiently with the spliceosome. Nature 349:494-499.

    Google Scholar 

  31. Iost, I. and Dreyfus, M. 1994. mRNAs can be stabilized by DEAD-box proteins. Nature 372:193-196.

    Google Scholar 

  32. Burd, C. G. and Dreyfuss, G. 1994. Conserved structures and diversity of functions of RNA-binding proteins. Science 265: 615-621.

    Google Scholar 

  33. Weitzdörfer, R., Fountoulakis, M., and Lubec, G. 2001. Aberrant expression of dihydropyriminidase related proteins 2, 3 and 4 in fetal Down syndrome brain. Pages 71-82, in Lubec, G. (ed.), Protein Expression in Down Syndrome Brain, Springer, Wien-New York.

    Google Scholar 

  34. Jensen, R. D. and Miller, R. W. 1971. Retinoblastoma: epidemiologic characteristics. N. Engl. J. Med. 285:307-311.

    Google Scholar 

  35. Hasle, H. and Clemmensen, I. C. H. 2000. Incidence of cancer in individuals with Down syndrome. Tidsskr. Nor Laegeforen 120:2878-2881.

    Google Scholar 

  36. Satge, D., Sasco, A. J., Carlsen, N. L. T., Stiller, C. A., Rubie, H., and Hero, B. 1998. A lack of neuroblastoma in Down syndrome: a study from 11 European countries. Cancer Res. 58:448-452.

    Google Scholar 

  37. Barger, S. W., Van Eldik, L. J., and Mattson, M. P. 1995. S100 beta protects hippocampal neurons from damage induced by glucose deprivation. Brain Res. 677:167-170.

    Google Scholar 

  38. Satge, D., Sasco, A. J., Carlsen, N. L. T., Rubie, H., and Stiller, C. A. 1997. A negative association between Down's syndrome and neuroblastoma. Arch. Dis. Child. 76:80.

    Google Scholar 

  39. Godbout, R. and Squire, J. 1993. Amplification of a DEAD box protein gene in retinoblastoma cell lines. Proc. Natl. Acad. Sci. U S A 90:7578-7582.

    Google Scholar 

  40. Makino, Y., Kanemaki, M., Kurokawa, Y., Koji, T. and Tamura, T.-A. 1999. A rat RuvB-like protein, TIP49a, is a germ cellenriched novel DNA helicase. J. Biol. Chem. 274:15329-15335.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Medical Chemistry, University of Vienna, Austria

    Susanne G. Kircher

  2. Department of Pediatrics, University of Vienna, Vienna, Austria

    Susanne G. Kircher, Seong Hwan Kim & Gert Lubec

  3. Pharmaceutical Research, Genomics Technologies, F. Hoffmann-La Roche, Ltd., Basel, Switzerland

    Michael Fountoulakis

Authors
  1. Susanne G. Kircher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Seong Hwan Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Fountoulakis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Gert Lubec
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kircher, S.G., Kim, S.H., Fountoulakis, M. et al. Reduced Levels of DEAD-Box Proteins DBP-RB and p72 in Fetal Down Syndrome Brains. Neurochem Res 27, 1141–1146 (2002). https://doi.org/10.1023/A:1020921324871

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1020921324871

Search

Navigation